The infralimbic subregion of the prefrontal cortex (IL) is broadly involved in behavioral flexibility, risk assessment, and outcome reinforcement. In aversive conditioning tasks, the IL has been implicated in fear extinction and in mediating transitions between Pavlovian and instrumental responses. Here we examine the role of the IL in mediating transitions between two competing Pavlovian fear responses, conditioned motor inhibition (CMI) and conditioned motor excitation (CME). Rats were trained to fear an auditory conditioned stimulus (CS) by pairing it with periorbital shock to one eyelid (the unconditioned stimulus [US]). Trained animals exhibited CMI responses (movement suppression) to the CS when they had not recently encountered the US (>24 hr), but, after recent encounters with the US (<5 min), the CS evoked CME responses (turning in circles away from anticipated shock). Animals then received bilateral infusions of muscimol or picrotoxin to inactivate or hyperactivate the IL, respectively. Neither drug reliably affected CMI responses, but there was a bidirectional effect on CME responses; inactivation of the IL attenuated CME responses, whereas hyperactivation potentiated CME responses. These results provide evidence that activation of the IL may promote behavioral strategies that involve mobilizing the body and suppress strategies that involve immobilizing the body. V C 2016 Wiley Periodicals, Inc.
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The ability to select appropriate defensive behaviors is an important survival skill. For example, an animal may exhibit immobilization behavior, such as freezing, to avoid detection by a nearby predator. However, if the animal has already been detected by the predator then freezing may no longer be the most appropriate defensive response for avoiding danger; the animal may then engage in mobilization behaviors, such as flight (Bolles, 1970; Fanselow and Lester, 1988) . Circuitry within the medial prefrontal cortex (mPFC) mediates shifting among different behavioral strategies in many kinds of tasks (Miller and Cohen, 2001; Rich and Shapiro, 2009 ) and may also mediate selection among different defensive response strategies. Supporting this, findings from both human and rodent studies suggest that the mPFC can modulate behavioral strategies for responding to threat (Wall et al., 2004; Mobbs et al., 2007; Moscarello and LeDoux, 2013; Bravo-Rivera et al., 2014; Harnett et al., 2015) . Evidence suggests that the mPFC mediates defensive responding by way of its connections with the amygdala (AMG; SierraMercado et al., 2011; Sotres-Bayon and Quirk, 2010; Orsini and Maren, 2012) and the periaqueductal gray (PAG; LeDoux et al., 1988; Bandler and DePaulis, 1988; Fanselow, 1991; Davis, 1992; Killcross et al., 1997; De Oca et al., 1998; Amorapanth et al., 2000; Mobbs et al., 2007 Mobbs et al., , 2009 Gozzi et al., 2010) , but the exact neural mechanisms for selection among competing defensive responses are not well understood.
SIGNIFICANCE
Anxiety disorders such as posttraumatic stress disorder (PTSD) are characterized by excessive and often inappropriate responses to aversive stimuli. By understanding the neural mechanisms underlying different responses to threat and the way in which defensive behaviors are selected, we will gain insight into improved treatments for disorders such as PTSD. This study provides evidence that the infralimbic cortex (IL) specifically mediates defensive behaviors elicited by imminent threat, such as flight, but not defensive behavior during more distant threat, such as freezing. These results suggest that the IL may serve as a potential therapeutic target for reducing excessive response to aversive stimuli.
Contract grant sponsor: National Institutes of Health; Contract grant numbers: R01 MH073700 (to H.T.B.); Contract grant number: 5 T32 NS058280-03 (to L.R.H.) *Correspondence to: Lindsay R. Halladay, 5625 Fishers Lane, Room 2N09, Rockville, MD 20852. E-mail: lindsay.halladay@nih.gov The infralimbic subregion of the mPFC (IL) is involved in the detection of aversive behavioral contingencies (Amat et al., 2005) as well as aspects of risk assessment (Wall et al., 2004) , so it seems likely that the IL could participate in mediating transitions among different defensive response strategies. In support of this, it has recently been reported that pharmacological inhibition of the IL increased Pavlovian freezing responses and concurrently decreased expression of instrumental avoidance responses , suggesting that the IL may promote avoidance behavior and inhibit freezing. Another study also indicated that IL inactivation increased freezing, but avoidance was unaffected (BravoRivera et al., 2014) , suggesting that the IL may not directly drive avoidance but could indirectly facilitate avoidance by inhibiting competing behaviors such as freezing. Although these findings indicate a role for the IL in defensive response selection, it remains unclear exactly what this role might be. Does the IL inhibit Pavlovian responses while exciting instrumental responses? Does it inhibit behaviors driven by fear while exciting behaviors driven by other motivational incentives? Perhaps it simply promotes body mobilization and inhibits body immobilization. Any of these possibilities could be consistent with existing evidence.
To investigate further the role of the IL in defensive strategy selection, we trained rats by pairing an auditory conditioned stimulus (CS; 20-sec train of white noise pips) with an aversive unconditioned stimulus (US; unilateral periorbital shock). As reported previously (Tarpley et al., 2010; Blair, 2012, 2015) , trained rats displayed either conditioned motor inhibition (CMI; i.e., movement suppression or freezing) or conditioned motor excitation (CME; i.e., turning in the direction away from anticipated shock), depending on whether they had recently encountered the US. CS-evoked CMI and CME were both Pavlovian fear responses (not instrumental responses) because neither response was ever reinforced by omission of the US or the CS. Using this paradigm, we pharmacologically manipulated the IL to determine its role in the selection of defensive response strategies. We found that inactivation of the IL with muscimol (MUS) blocked CME responses, and hyperactivation of the IL with picrotoxin (PTX) enhanced CME responses. From these findings, we argue that one function of the IL may be to promote behaviors that require body mobilization (or inhibit behaviors that require body immobilization).
MATERIALS AND METHODS

Subjects and Surgery
Adult male Long-Evans rats (RGD ID:2308852; Charles River Laboratories, Hollister, CA) weighing 350-400 g were housed singly and reduced to 85% of their free-feeding weight by daily limited feeding. During surgery, all rats were deeply anesthetized with isofluorane and implanted with a pair of insulated stainless-steel wires (75-lm diameter) threaded into the skin of each eyelid for delivering the periorbital shock US. Rats (n 5 36; 30 were included in the study and six were excluded because of misplaced infusion cannulae or faulty eyelid wires) were implanted with a pair of 26-gauge microinjector guide cannulae (Plastics One, Roanoake, VA) targeted bilaterally in the IL (2.5 mm anterior, 0.5 mm lateral, and 4.8 mm ventral to bregma) at an angle of 288 to prevent drug diffusion into areas immediately dorsal to the target region. All experimental procedures were approved by the UCLA animal research committee and were conducted in accordance with the NIH Guide for the care and use of laboratory animals and the Society for Neuroscience policies on the use of animals and humans in research.
Fear Conditioning
After recovery from surgery, rats were habituated for 5 days (20 min/day) to the experimental context (which was a 70-cm 3 70-cm elevated platform) before any fear conditioning sessions were conducted. To provide a baseline of motor activity against which stimulus-evoked movement and turning behavior could be measured, rats constantly foraged for 20-mg purified food pellets (Bioserv, Frenchtown, NJ), dropped from an overhead dispenser at 30-sec intervals throughout all preexposure and fear conditioning sessions. For 5 days following pre-exposure, rats received an identical regimen of fear conditioning trials, six CS-alone presentations (test trials) immediately followed by 16 CS-US pairings (training trials). The CS was a train of 70-dB white noise pips, each lasting for 250 msec, delivered at 1 Hz for 20 sec through an overhead speaker. The US was a train of 2.0-mA shock pulses, each lasting for 2.0 msec, delivered to one eyelid at a rate of 6.66 Hz for 2 sec. During CS-US pairing trials, the first shock pulse was always delivered 300 msec after the offset of the final (20th) CS pip. The intertrial interval was uniformly random between 180 and 240 sec.
Behavioral Data Acquisition and Analysis
The rat's position on the experimental platform was sampled at 30 Hz by an overhead video tracking system (Neuralynx Corporation, Bozeman, MT), which monitored the location of three light-emitting diodes of different colors (red, blue, and green) attached to the animal's headstage for automated measurement of movement speed and turning behavior (see Tarpley et al., 2010; Halladay and Blair, 2012) . Conditioned fear responses were assessed by comparing the animal's behavior during the context (CX) period, defined as the 20 sec immediately preceding CS onset, vs. the CS period, the 19 sec immediately following CS onset (the 20th pip was omitted from the CS period because the first shock pulse was delivered <1 sec after the offset of this pip).
CS suppression ratio. Suppression of movement (CMI) during the CS was measured for each experimental trial by measuring the ratio of average movement speeds during the CX vs. the CS period. The formula for computing the CS suppression ratio (R CS ) was R CS 5 S CS /(S CX 1 S CS ), where S CS and S CX were the mean movement speeds during the CS vs. the CX period, respectively. US suppression ratio. Suppression of movement (CMI) following delivery of the first shock US (beginning of the postshock portion of each session) was measured for each experimental session by computing the ratio of average movement speeds during the CX periods of pre-vs. postshock trials. The US suppression ratio (R US ) was computed as R US 5 S POST /(S POST 1 S PRE ), where S POST and S PRE were the mean movement speeds during the CX period of the session's postvs. preshock trials, respectively.
Intracranial Drug Infusions
Rats were given unilateral or bilateral injections of the GABA agonist MUS to inactivate the mPFC or the GABA antagonist PTX to hyperactivate the mPFC. After 5 days of training in the fear conditioning task, rats received presession infusions of different drugs on different days in a counterbalanced repeated-measures design. A drug-free (DF) retraining session was always conducted between each infusion session. Among the 30 rats that were included in the data analysis (see above under Subjects and surgery), 14 rats received infusions of MUS only (into the left, right, or both hemispheres on different days in counterbalanced order), 13 rats received infusions of PTX only (bilaterally on the first day following the fifth training session), and three rats received infusions of both drugs (these three rats received bilateral MUS infusions on the first day following the fifth training session and then a DF retraining day, followed by bilateral PTX infusions). Thus, data were analyzed from a total of 17 bilateral MUS infusions, 16 unilateral MUS infusions (because one of the MUS rats received only bilateral infusions), and 16 bilateral PTX infusions in a total of 30 rats, with no rat receiving the same infusion twice. MUS infusions were carried out both unilaterally and bilaterally to determine whether the IL's role in mediating CME is hemispherically lateralized because previous experiments in our laboratory (Tarpley et al., 2010) have shown unilateral effects on CME resulting from MUS infusions in both AMG and PAG. PTX was infused only bilaterally because there were no pronounced or interesting effects of unilateral MUS.
Both drugs were dissolved in 0.9% sterile saline, and a total volume of 0.4 ll per hemisphere was infused into the mPFC through 26-gauge injectors at a rate of 0.2 ll/min. MUS was dissolved at a concentration of 0.25 mg/ml, and PTX was dissolved at a concentration of 0.20 mg/ml. Prior to drug infusion, dummy cannulae (which were in place at all times except during infusions to prevent clogging of the guide cannulae) were removed, and injector cannulae were inserted in their place. After drug infusions, the injectors were left in place for an additional 2 min to allow diffusion of the drug away from the cannulae tip, after which the injectors were removed and replaced with dummy cannulae. Throughout the infusion process, the animal was held gently on the experimenter's lap. After the infusion was complete, the rat was returned to its home cage for 15 min to allow time for the drug to take effect before the experiment resumed.
Injector Placements and Drug Diffusion
Cannula guides were bilaterally implanted into the mPFC at a lateral-to-medial angle of 288 (Fig. 1A) , with injector tips targeted at the IL (Fig. 1B) . Analysis of fluorescence-tagged MUS diffusion (see below under Histological procedures) indicated that drug concentrations were highest surrounding the injector tip in the IL. We assume that PTX diffusion patterns were similar to those observed for MUS, but we cannot rule out the possibility that PTX diffusion patterns differed because PTX molecular properties are not identical to those of MUS.
Statistical Analysis
Statistical analyses were performed in Statistica (StatSoft, Tulsa, OK) software on a PC running Microsoft (Redmond, WA) Windows. For consistency, post hoc comparisons for all ANOVAs were performed by the Newman-Keuls method, unless otherwise noted.
Histological Procedures
At the end of the experiment, rats were intraperitoneally injected with an overdose of pentobarbital (100 mg/kg) and perfused intracardially. Brains were extracted and fixed in a formalin sucrose solution. Tissue was later sectioned into 40-lm slices and mounted on slides for cannula placement verification. To assess the extent of drug diffusion, cannula-implanted rats that had previously received MUS injections were given a final infusion of fluorescent MUS (tagged with Bodipy TMR-X fluorophore; catalog No. M2400; Invitrogen, Carlsbad, CA) into the IL at the same volume, concentration, and rate that had been used for infusions of nonfluorescent MUS in behavioral Reconstructed cannula tip placements in mPFC (n 5 30 per hemisphere) at 12.5 mm anterior to bregma are overlaid on a coronal template from the atlas of Paxinos and Watson (1997) ; symbols indicate rats infused with MUS (circles) or PTX (squares). PL, prelimbic cortex; AC, cingulate cortex. experiments (see above under Intracranial drug infusions). Fluorescent MUS was infused 30 min prior to the pentobarbital injection.
RESULTS
Pharmacological inactivation of either AMG or PAG has previously been shown to impair CMI and CME responses in the fear conditioning task used here (Tarpley et al., 2010) . To investigate the contribution of the IL to CMI and CME behaviors, we pharmacologically inactivated (with MUS) or hyperactivated (with PTX) the IL.
Movement Suppression as a Measure of CMI Responses
To quantify CMI responses evoked by the CS, a movement suppression ratio denoted R CS was computed to compare movement speed during the CS relative to the CX on each experimental trial; R CS < 0.5 indicates suppression of movement during the CS, R CS > 0.5 indicates enhancement of movement during the CS, and R CS 5 0.5 indicates that the CS has no effect on movement (see Materials and Methods). Figure 2A shows mean R CS values on each trial for all rats (n 5 30), averaged on the day prior to the rat's first bilateral drug infusion of either MUS or PTX (whichever came first). Z-tests revealed that R CS was significantly less than 0.5 for every individual preshock trial and for the mean of all preshock trials (z 29 5 3.83, P 5 0.0006). However, R CS did not differ significantly from 0.5 for any individual trial subsequent to the first postshock trial, and, consequently, the mean of R CS averaged across postshock trials for all rats did not differ significantly from 0.5 (z 29 5 0.56, P 5 0.58). A paired t-test revealed that R CS differed significantly between pre-vs. postshock trials (t 29 5 3.14, P 5 0.004), indicating that CMI responses were evoked by the CS during preshock but not postshock trials. For this reason, analyses presented below evaluate drug effects on CMI responses during preshock trials only.
Turning Bias as a Measure of CME Responses
One reason the CS failed to evoke CMI responses (as measured by R CS ) during postshock trials (Fig. 1A) was that, after recent encounters with shock US, rats began responding to the CS by expressing a CME response on some trials, which often included turning in the direction away from the eyelid for which shock was anticipated (Tarpley et al., 2010; Blair, 2012, 2015; see Fig. 2B ). To quantify this CME response, we computed the rat's mean turning velocity in the direction away from the anticipated eyelid shock. Figure 2B shows mean angular velocities for the DF condition, with positive velocities indicating a bias for turning away from the trained eyelid and negative velocities indicating a bias for turning toward the trained eyelid. Turning bias data for preshock and postshock trials were analyzed by 2 3 2 ANOVA, with stimulus (CX vs. CS) and trial type (preshock vs. postshock) as repeated factors. There was a significant interaction between stimulus and trial type (F 1,29 5 21.94, P < 0.00001), and post hoc comparisons revealed that turning bias did not differ during the CS vs. the CX (P 5 0.34) for preshock trials (because the CS did not evoke CME responses during preshock trials), but, for postshock trials, the CS evoked robust turning behavior compared with both the postshock CX (P 5 0.0001) and the preshock CS (P 5 0.0002). These results indicate that CME responses (as measured by turning bias) were evoked by the CS during postshock but not preshock trials, as reported previously (Tarpley et al., 2010; Blair, 2012, 2015) and in experiments described above (see Fig. 2B ). For this reason, analyses presented below evaluate drug effects during postshock trials only.
Postshock Movement Suppression as a Measure of US Aversiveness
A main reason why the CS failed to evoke CMI responses during postshock trials (as measured by R CS ; see Fig. 2A ) is that, after shock delivery, movement speed was tonically suppressed during the CX period (stimulus 3 trial type, F 1,29 5 21.70, P < 0.0001). Post hoc comparisons showed that, during preshock trials, rats exhibited suppression of their movement speed during the CS compared with the CX (P 5 0.0002), but, during postshock trials, movement speeds during the CX were lower (P 5 0.0002), and there was no longer a significant difference between CX and CS movement speeds during postshock trials (P 5 0.37). This floor effect on movement speed made it difficult to observe CS-evoked CMI during postshock trials (Tarpley et al., 2010; Blair, 2012, 2015) .
To quantify this suppression of movement speed during the CX period of postshock trials, a suppression ratio denoted R US was computed to compare mean movement speeds during the CX for pre-vs. postshock trials in each session (see Materials and Methods). Figure  2A shows that R US was significantly less than 0.5 when averaged across rats (z 29 5 3.33, P 5 0.002). Hence, movement speed was suppressed during the CX period of postshock trials compared with preshock trials. Presumably, this was a consequence of postshock fear induced by the aversive US. With the assumption that postshock fear is proportional to the aversiveness of the US, R US can be regarded as a quantitative (albeit indirect) measure for the aversive valence of the US. We thus analyzed R US along with other US-evoked movement speed to assess how US aversiveness was affected by pharmacological manipulations (see below).
Drug Effects on CMI Responses
Analysis of CX movement speeds during the preshock trials showed no significant differences in movement speed for DF baseline sessions compared with bilateral MUS (paired t 16 5 1.04, P 5 0.31) or PTX (paired t 15 5 0.71, P 5 0.49) infusion sessions. This is consistent with prior studies that reported that intra-IL infusions administered in a novel context (nonfear conditioned animals) had no locomotor effects for either MUS (Slattery et al., 2011; Jiang et al., 2014) or PTX (Ronzoni et al., 2016) . Thus, any effects resulting from MUS or PTX infusions are assumed to be attributed to druginduced changes in defensive behavior. Figure 3A shows how R CS was affected by MUS or PTX infusions that inactivated or hyperactivated, respectively, the IL. All PTX infusions (n 5 16) were bilateral, whereas MUS infusions were given into different hemispheres on different days (bilateral, n 5 17; contralateral to trained eyelid, n 5 16; ipsilateral to trained eyelid, n 5 16) in a repeated-measures design (see Materials and Methods). Unilateral infusions of MUS were given to test whether the IL's role in regulating CME might be hemispherically lateralized because prior evidence indicates that MUS infusions into AMG and PAG can produce lateralized effects on turning behavior (Tarpley et al., 2010) . R CS values were averaged separately for each infusion type during pre-vs. postshock trials and compared against a DF baseline session given on the day immediately prior to each infusion. Z-tests revealed significant CMI responses (R CS < 0.5) during preshock trials for all DF conditions (Fig. 3A) . Z-tests revealed that significant CMI responses (R CS < 0.5) persisted during preshock trials after all MUS infusions, without regard to hemisphere (Fig. 3A) . Post hoc comparisons revealed that R CS was unchanged from the DF condition after unilateral MUS infusions into either hemisphere (contralateral, P 5 0.66; ipsilateral, P 5 0.43; see Fig. 2A ). This pattern of results indicates that MUS infusions into the IL never significantly impaired CMI responses to the CS during preshock trials, without regard to whether MUS was infused bilaterally or unilaterally, which is consistent with prior evidence that bilateral inactivation of the IL does not impair expression of conditioned freezing to an auditory CS (Sierra-Mercado et al., 2011).
CS-evoked CMI responses were no longer significant (that is, R CS did not differ from 0.5) after PTX infusions (z 1,16 5 0.11, P 5 0.92), but this was largely attributable to greatly increased variance of R CS after PTX infusions (Fig. 3A) . Some of this variability resulted from two outlying animals that exhibited R CS > 0.7 after PTX, which was far outside the range observed for any other rat under any other condition. When these two outlying rats were removed from the analysis (Fig. 3A) , the mean R CS value was quite similar to the predrug condition, but the variance was still considerably higher, and, consequently, R CS did not differ significantly from 0.5 after PTX. These findings suggest that PTX might have had a disruptive influence on CMI behavior in some rats, consistent with prior data showing that expression of context freezing can be impaired by infusions of PTX into the IL (Thompson et al., 2010) . However, the high variability in R CS after PTX makes it difficult to draw firm conclusions about reliable effects of PTX on CMI behavior during preshock test trials.
Drug Effects on CME Responses
Z-tests revealed that significant turning away from the shocked eyelid was observed during postshock trials under all conditions except after bilateral MUS (Fig. 3B) . Therefore, bilateral MUS was the only drug infusion that appeared to block CME responses to the CS during postshock trials. Effects of MUS and PTX infusions on CME responses were more closely analyzed by performing 2 3 2 ANOVAs on turning bias scores with drug (DF vs. infusion) and trial type (preshock vs. postshock) as repeated-measures factors. As expected, CME responses were preferentially expressed during postshock trials, yielding a significant main effect of trial type for bilateral (F 1,16 5 8.05, P 5 0.01) and unilateral (contralateral, F 1,15 5 17.29, P 5 0.0008; ipsilateral, F 1,15 5 25.77, P 5 0.0001) MUS infusions as well as for PTX infusions (F 1,15 5 14.85, P 5 0.002). The drug main effect of MUS was significant only after bilateral (F 1,16 5 8.71, P 5 0.009) but not after unilateral (contralateral, F 1,15 5 1.01, P 5 0.33; ipsilateral, F 1,15 5 3.03, P 5 0.10) infusions.
Because both factors were treated as repeated measures in the ANOVA, the significance of posthoc comparisons depended on within-subject variance (rather than the between-subject variance plotted in Fig. 3B ). Figure 4 shows within-subject means and standard errors for the predrug vs. postdrug change in turning bias during the CS of postshock trials. As shown in Figure 4 , post hoc comparisons revealed that animals exhibited significantly less turning (P 5 0.002) during the CS of postshock trials after bilateral MUS than in the DF baseline condition. CS-evoked turning was also attenuated by unilateral MUS infusions, but post hoc comparisons did not quite reach significance for either hemisphere (contralateral, P 5 0.06; ipsilateral, P 5 0.06). The effect size of this trend was similar in both hemispheres, implying that CSevoked turning was partially impaired after unilateral MUS infusions into either hemisphere. Therefore, there did not appear to be a hemispherically lateralized effect of IL inactivation on turning responses, in contrast top laterality effects that have previously been observed following inactivation of AMG or PAG (Tarpley et al., 2010) . However, given the close anatomical proximity of the IL to the midline, it is possible that unilateral infusions may have diffused across the midline to affect both hemispheres. If so, then the reduced impairment of turning after unilateral infusions might simply reflect a decrease in the dose of MUS delivered to both hemispheres.
Bilateral infusions of PTX had effects opposite from MUS, enhancing rather than impairing turning responses (Fig. 4) . The 2 3 2 ANOVA yielded a significant main effect of PTX (F 1,16 5 8.14, P 5 0.01) but no interaction (F 1,16 5 0.26, P 5 0.63). Post hoc comparisons revealed that animals exhibited significantly more CS-evoked turning during postshock trials after PTX compared with the DF condition (P 5 0.009); on average, PTX increased a rat's turning bias by 5.58 6 2.48 compared with the DF condition (Fig. 4) , suggesting that PTX infusions not only failed to disrupt CS-evoked turning but might even have enhanced it. One possible confound for this interpretation is that turning for the pre-PTX DF condition was lower than for the DF condition preceding Fig. 3 . Effects of MUS and PTX on CMI vs. CME responses. In all graphs, DF data are plotted with open symbols and drug-infusion data are plotted with solid symbols. A: CS significantly suppressed movement (R CS < 0.5) before and after MUS infusions but not after PTX infusions; asterisks indicate significance levels for z-test comparisons against R CS 5 0.5. B: Defensive turning bias during the CS period of pre-and postshock trials after MUS vs. PTX infusions; asterisks indicate significance levels for z-test comparisons against zero turning bias. C: US-evoked reflex responses following MUS and PTX; carat symbols indicate significance levels for paired Newman-Keuls tests comparing movement speed during CX vs. US for postshock trials (ÙÙÙP < 0.001). D: Shock-induced movement suppression (R US ) scores after infusions of MUS and PTX. *P < 0.05, **P < 0.01, ***P < 0.001, significance levels for z-test comparisons against R US 5 0.5. other infusions, raising concerns that the effect might have arisen from a change in the control condition rather than from the experimental condition. However, oneway repeated-measures ANOVA (including only the rats that were given all four drug treatments) indicated no significant differences in postshock CS-evoked turning scores across the four DF sessions preceding drug infusions (F 1,3 5 1.73, P 5 0.18). Moreover, when the two outlying rats that responded differently to PTX were excluded from the analysis, the DF turning scores became more similar to those in other conditions (Fig. 2B) , and the significant increase in CS-evoked turning after PTX persisted (P 5 0.008). In summary, hyperactivation of the IL by PTX did not impair CME responses but instead enhanced these responses during postshock trials.
US-Evoked Reflexes and Movement Suppression
CS-evoked turning responses emerged only during postshock trials (after delivery of the shock US) on each experiment day, so it is important to consider whether observed effects of MUS and PTX on turning behavior might have resulted from drug-induced alterations in processing of the shock US. To assess whether US processing was altered by drug infusions, we performed analyses on unconditioned reflex responses to the shock and shock-induced suppression of movement (R US ) during the CX period of postshock trials.
Effects of MUS and PTX on unconditioned reflex responses were assessed by performing separate 2 3 2 ANOVAs (one for each infusion condition) of USevoked movement speed with drug (DF vs. infusions) and stimulus (CX vs. US) as repeated factors (Fig. 3C) . The main effect of stimulus was significant for all MUS (bilateral, F 1,16 5 35.11, P < 0.0001; contralateral, F 1,15 5 29.54, P 5 0.00007; ipsilateral, F 1,15 5 33.52, P < 0.00001) and PTX (F 1,16 5 17.96, P 5 0.0007) infusions, so US-evoked reflex responses were never abolished. There was no main effect of drug (F 1,16 5 2.12, P 5 0.16) or drug-by-stimulus interaction (F 1,16 5 2.12, P 5 0.16) for bilateral MUS. There also was no main effect of drug for ipsilateral MUS (F 1,15 5 1.46, P 5 0.25), but the interaction approached significance (F 1,15 5 4.09, P 5 0.06), and post hoc comparisons revealed that this was entirely accounted for by an increase in movement speed during the CX (P 5 0.03) rather than a decrease in movement speed during the US (P 5 0.67), so USevoked responding was not altered by ipsilateral MUS. The drug main effect was significant for contralateral MUS (F 1,15 5 5.9, P 5 0.03), but the interaction was not (F 1,15 5 0.01, P 5 0.92), because movement speed increased by the same amount during the CX and US, implying no major effects of contralateral MUS on USevoked reflexes. There was no main effect of drug for PTX infusions (F 1,16 5 0.2, P 5 0.66), and, although the interaction was significant (F 1,16 5 4.46, P 5 0.05), post hoc comparisons showed that, after PTX, movement speed was nonsignificantly increased during the CX (P 5 0.26) and nonsignificantly decreased during the US (P 5 0.09), implying no major effects of PTX on US processing.
Effects of MUS and PTX on postshock movement suppression were assessed by analyzing R US with 4 3 2 ANOVA with drug (DF vs. infusion) as a repeated factor and infusion type (bilateral MUS, contralateral MUS, ipsilateral MUS, and bilateral PTX) as an independent factor (Fig. 3D) . Neither drug (F 1,62 5 0.79, P 5 0.38) nor infusion type (F 3,62 5 0.52, P 5 0.67) was found to affect R US significantly, and the interaction also was not significant (F 3,62 5 0.08, P 5 0.97), suggesting that US delivery during postshock trials reduced CX movement speeds similarly for all conditions. This pattern of results indicates that neither MUS nor PTX had any effect on the general aversiveness of the US, as assessed by its ability to suppress movement during subsequent CX periods. In summary, it appears that sensory processing and aversiveness of the US were not greatly altered by infusions of MUS or PTX.
DISCUSSION
Consistent with theories of predatory imminence (Bolles, 1970; Fanselow and Lester, 1988) and our past data (Tarpley et al., 2010; Blair, 2012, 2015) , in response to CS presentations, rats in this study exhibited either CMI or CME behaviors that were dependent on whether the animal had recently encountered the US. As previously reported by other researchers (Laurent and Westbrook, 2009; Sotres-Bayon et al., 2009; SierraMercado et al., 2011) , manipulations of the IL had no effect on CMI responses. However, pharmacological manipulation of the IL affected the expression of CME Fig. 4 . Effects of MUS and PTX on CS-evoked turning during postshock trials. Each bar shows the mean and standard error of the within-subject change in turning bias after drug infusion compared with the DF session on the previous day. Data for PTX include n 5 16 subjects (outliers included). **P < 0.01, †P 5 0.06. behaviors in a bidirectional manner; bilateral inactivation of the IL attenuated conditioned turning responses, whereas hyperactivation of the IL potentiated defensive turning, suggesting that activity in the IL might help to drive the transition from reactive to active defensive responding. This is in agreement with the idea that the IL is essential for some forms of risk assessment (Wall et al., 2004) , behavioral flexibility (Ragozzino et al., 1999 (Ragozzino et al., , 2003 Delatour and Gisquet-Verrier, 2000; Dias and Aggleton, 2000) , and the integration of cognition and behavior (Sullivan and Gratton, 2002) .
IL Regulates Body Mobilization
Several lines of evidence suggest that the IL might play a role in active avoidance tasks, in which a CS that is initially trained to evoke Pavlovian freezing responses (a CMI behavior) can later come to evoke instrumental avoidance responses (a CME behavior) after the avoidance responses have been reinforced by the absence of the US that was previously predicted by the CS (Mowrer and Lamoreaux, 1946) . Active avoidance induces c-fos expression in the IL that correlates with the extent of active avoidance expressed (Martinez et al., 2013) . Moscarello and LeDoux (2013) found that pharmacological inhibition of the IL increased freezing and concurrently decreased expression of active avoidance responses, suggesting that the IL might promote CME defenses and inhibit CMI defenses. However, another study showed that IL inactivation increased freezing but left active avoidance unaffected (Bravo-Rivera et al., 2014) , which suggests that the IL might not directly drive expression of CME defenses (such as avoidance) but could instead indirectly facilitate CME behavior by inhibiting competition from CME responses (such as freezing). Here, we found that IL inactivation impaired CME responses but spared CMI responses, but, unlike prior studies, the CME responses measured here (defensive turning) were never reinforced by withholding shock, so acquisition of CME responses in our paradigm cannot be attributed to instrumental learning (Tarpley et al., 2010) . This is an important difference from prior studies because there has long been controversy about whether animals can really learn to express instrumental avoidance responses when they are in a fearful state (Bolles, 1970) . Before instrumental avoidance responses can be learned, it may be necessary first to suppress fear; then the role of the IL in avoidance learning may be to inhibit fear. This would be consistent with prior evidence that the IL facilitates extinction learning (Bukalo et al., 2015; Do-Monte et al., 2015) . However, in our paradigm, it seems unlikely that rats were less afraid during CME responses than during CMI responses (if anything, rats should have been more afraid because they had more recently been shocked); thus, it seems unlikely that the IL promoted turning behavior by suppressing fear or by suppressing Pavlovian responses in favor of instrumental responses. Instead, the IL might have influenced defensive action selection by promoting CME behaviors (such as turning) that mobilize the body while, possibly, also inhibiting CMI behaviors (such as freezing) that immobilize the body, independently of the animal's emotive state or of Pavlovian vs. instrumental contingencies. This interpretation is consistent with recent evidence that neural activity in the AMG might also be correlated with body movements, independently from motivational states (Amir et al., 2015) .
IL Drives Contextually Appropriate Defensive Responding
Another possibility to consider is that the IL plays a role in risk assessment processes that underlie contextdependent defensive action selection. The PFC is thought to mediate contextually driven action selection; not only does it seem to modulate initiation of contextually appropriate actions (Sierra-Mercado et al., 2011; Moorman and Aston-Jones, 2015) but it also plays a role in the inhibition of contextually inappropriate behaviors (Orsini et al., 2011; Maren et al., 2013) . Electrophysiological recording studies have shown that action-selective cells in the PFC are modulated by contextual components that may include spatial location, time, sensory attributes, and response-outcome contingencies (Halladay and Blair, 2015; Moorman and Aston-Jones, 2015) . The experimental paradigm used here can be thought of as containing two distinct contexts, characterized by sequential order (time) and by the presence or absence of US reinforcement (sensory attribute). On any given day, the initial context consisted of nonreinforced CS presentations, during which CMI expression was a contextually appropriate reactive behavior. However, after the initial shock following the seventh CS presentation signaled the onset of a new, US-reinforced context, the change in cue-outcome contingency rendered CMI no longer the most appropriate action, and, thus, active CME behaviors emerged. However, after IL inactivation, animals were incapable of adapting to the change in context, which resulted in a failure to execute contextually appropriate CME defenses. This is consistent with prior evidence implicating the PFC as a mediator of behavioral flexibility with regard to risk assessment (Wall et al., 2004) , reinforcement prediction (Maddux and Holland, 2011) , and contextual control of action (Ashwell and Ito, 2014; Moorman and Aston-Jones, 2015) .
IL Modulates Downstream Structures
Recent electrophysiological recording experiments from our laboratory showed that the PFC contains defensive strategy-specific neuronal populations whose tonic firing rates may mediate the expression of CMI and CME defenses (Halladay and Blair, 2015) . These cells likely interact with downstream structures to regulate behavioral strategies (Miller and Cohen, 2001 ). These downstream structures include the AMG, which stores information about CS-US associations (Davis, 1992; Blair et al., 2003 Blair et al., , 2005 Maren, 2003; Herry and Johansen, 2014) and modulates both reactive and active defensive strategies by way of its distinct pathways (Killcross et al., 1997; Amorapanth et al., 2000; Gozzi et al., 2010) . Although reactive defenses such as CMI are mediated primarily by the central nucleus of AMG (CeA), active responses may be mediated by the basal nucleus of AMG (BA) and basolateral nucleus of AMG (BLA; Killcross et al., 1997; Amorapanth et al., 2000) . Thus, it is possible that the IL interacts with the AMG in a way that promotes activity in BA and/or BLA while inhibiting CeA. Traditionally, the IL has been thought to mediate fear extinction by inhibiting CeA output, which attenuates freezing behavior (SotresBayon and Quirk, 2010; Orsini and Maren, 2012 ; but see Do-Monte et al., 2015) . Although many interpret this as evidence that the IL inhibits fear, we posit that activity in the PFC is correlated with specific defensive action rather than affect (Halladay and Blair, 2015) . Data presented here support this position because neither inactivation nor hyperactivation of the IL fully blocked the expression of fear (i.e., CMI or CME) but instead changed the nature of its expression.
Other downstream targets of the IL include the ventral PAG (vPAG; Floyd et al., 2000) , which drives CMI defenses (De Oca et al., 1988; Fanselow, 1991; Vianna et al., 2001 ) and directly competes with the dorsal PAG (dPAG), which drives CME defenses (Bandler and Depaulis, 1988; Fanselow, 1991; Walker et al., 1997) . It seems possible that PAG innervation from the IL may modulate the competition between vPAG and dPAG by inhibiting vPAG output, thus allowing dPAG to drive CME behaviors. Alternatively, the ventral striatum (vSTR) has been implicated in avoidance expression and receives inhibitory input from the PFC that may mediate active avoidance (Bravo-Rivera et al., 2014 Lee et al., 2014) and escape behavior (Richard and Berridge, 2013) . Interactions between the IL and the vSTR might also influence the emergence of CME behaviors following recent encounters with shock. Although it is evident that the IL plays a role in mediating defensive strategy selection, further investigation is required to determine which other structures, if any, interact with the IL to control the gating of reactive and active defenses.
